Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bollen

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
AJNR. American Journal of Neuroradiology|April 14, 2006
Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurementD M J van den Heuvel, V H ten Dam, A J M de Craen, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
Journal of the American Geriatrics Society|November 6, 2007
Association between apolipoprotein E4 and cognitive decline in elderly adultsChris J Packard, Rudi G J Westendorp, David J Stott, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
AJNR. American Journal of Neuroradiology|April 14, 2006
Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurementD M J van den Heuvel, V H ten Dam, A J M de Craen, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
Journal of the American Geriatrics Society|November 6, 2007
Association between apolipoprotein E4 and cognitive decline in elderly adultsChris J Packard, Rudi G J Westendorp, David J Stott, et al.
Pageof 25